Wenlong Bao
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Randomized Controlled Trial.
Journal: Journal of pain research
Published: January 26, 2026
Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Pilot Randomized Controlled Trial.
Journal: International journal of women's health
Published: January 12, 2026
Electroacupuncture for chemotherapy-induced hemifacial spasm: a case report.
Journal: Frontiers in medicine
Published: September 07, 2025
Effects of Electroacupuncture and Mecobalamin for Utidelon-Induced Peripheral Neuropathy in Breast Cancer Patients: A Randomized Controlled Clinical Trial.
Journal: Journal of pain research
Published: March 05, 2025
Surufatinib related nephrotic syndrome in a pancreatic neuroendocrine tumor: a case report and review of literature.
Journal: Frontiers in oncology
Published: December 16, 2024
Efficacy of electroacupuncture with different frequencies in the treatment of chemotherapy-induced peripheral neuropathy: A study protocol for a randomized controlled trial.
Journal: Frontiers in neurology
Published: January 21, 2022
Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer.
Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre
Published: September 14, 2014
Association between polymorphisms in CHRNA3 and PHACTR2 gene and environment and NSCLC risk in Chinese population.
Journal: Acta biochimica Polonica
Published: March 21, 2014
Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.
Journal: Medical oncology (Northwood, London, England)
Published: February 17, 2014
A new receptor tyrosine kinase inhibitor, icotinib, for patients with lung adenocarcinoma cancer without indication for chemotherapy.
Journal: Oncology letters
Published: November 17, 2013
Last Updated: 09/26/2026